ArticleAnnals of surgical oncology2026
Evaluation of Clinical Outcomes and Graft Patency Following Venous Resection and Vascular Reconstruction Using a Recanalized Ligamentum Teres Hepatis Graft in Pancreaticoduodenectomy.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeOur objective was to evaluate clinical outcomes and vascular graft patency following portal vein/superior mesenteric vein (PV/SMV) reconstruction using recanalized autologous ligamentum teres hepatis (LTH) grafts.
methodsThis study enrolled 387 patients, stratified into three groups: (1) pancreaticoduodenectomy alone, (2) pancreaticoduodenectomy with vascular resection and reconstruction via end-to-end anastomoses or lateral venorrhaphy, and (3) pancreaticoduodenectomy with PV/SMV resection and reconstruction using autologous LTH grafts. This retrospective study compared operative time, intraoperative blood loss, postoperative complication rates, mortality, and length of postoperative hospital stay across these groups.
resultsThe study included 336 patients who underwent pancreaticoduodenectomy, 23 who underwent pancreaticoduodenectomy with vascular resection and reconstruction via end-to-end anastomosis or lateral venorrhaphy, and 28 who underwent pancreaticoduodenectomy with PV/SMV resection and reconstruction using autologous LTH grafts. The group using autologous LTH grafts exhibited an operative time of 484.86 ± 103.77 (285-685) min; intraoperative blood loss of 236.79 ± 141.95 (80-800) mL; a postoperative complication rate of 42.86%; 30-day mortality rate of 7.14%; and postoperative hospital stay of 20.82 ± 8.25 (9-49) days. Statistical analysis revealed a significantly longer operative time in the autologous LTH grafts group than in the other groups (p < 0.001), with no significant intergroup differences in blood loss, postoperative complication rates, mortality, or hospitalization. Partial thrombosis involving ≤50% of vessel diameter without obstruction was observed in four cases involving autologous LTH grafts. All reconstructed vessels maintained 100% patency throughout the follow-up period.
conclusionsUsing autologous LTH grafts for PV/SMV reconstruction during pancreaticoduodenectomy was safe and feasible, demonstrating favorable vascular graft patency rates and supporting its role as a viable alternative conduit for vascular restoration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.